Synchron lands NIH grant for brain computer interface trial

By The Science Advisory Board staff writers

August 27, 2021 -- Synchron has been awarded a $10 million grant by the U.S. National Institutes of Health (NIH) to study its Synchron motor neuroprosthesis in a new clinical trial. Synchron received the grant along with Carnegie Mellon University, University of Pittsburgh Medical Center, and Mount Sinai Health System.

The company said the U.S. trial, known as COMMAND, is another step for its implantable Stentrode brain computer interface to become commercially available. Stentrode converts the thoughts associated with attempted movement into cursor and keyboard commands.

The trial will evaluate the safety and efficacy of Stentrode in six severely paralyzed patients in the U.S. for regaining digital communication and functional independence, the company said. Synchron is also continuing to evaluate the device in the SWITCH human clinical trial in Australia.


Copyright © 2021 scienceboard.net


Conferences
Interphex 2021
October 19-21
New York City, New York United States
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter